The expression analysis of FGFR1, FGFR2, FGFR3, and FGFR4 was then validated in three independent validation cohorts consisting of a total of 293 HCC cases (GSE14323, GSE78737, and GSE6764) (Table 3). Here, FGFR1 is linked to hepatocellular carcinoma.